BrainSee

Curated by Signal

AI and cloud-based tool for detection of brain diseases

Overview

AI and cloud-based tool for detection of brain diseases. The company has developed a product 'Darmiyan' that uses AI technology to detecting neurodegenerative disease at its early stages. It has features for brain MRI scan analysis, therapeutic management, and more.

Key facts

Founded: 2022
Headquarters: Berkeley, United States
Stage: Sign up to view
Industry: Health Technology

Business model

4 products and services: Sign up to view

Contact

Email: Sign up to view

More on Vanberra Signal

Members only

Business overviewCore metrics and financials PeopleLeadership and key people Similar companiesPeers and competitors Deep AnalysisAI-generated strategic report

Competitors & similar companies

More Health Technology companies

Pharmbid
Platform for hospitals to request bids from pharma vendors
Health TechnologyUnited States
FINDconnect
Provider of community health solutions for healthcare providers and caregivers
Health TechnologyOakland, United States
HealthTrunk
Patient and provider faced application for medical records and information
Health TechnologyAtlanta, United States

About BrainSee

What does BrainSee do?

AI and cloud-based tool for detection of brain diseases.

Where is BrainSee headquartered?

BrainSee is headquartered in Berkeley, United States.

When was BrainSee founded?

BrainSee was founded in 2022.

Which sector is BrainSee in?

BrainSee operates in Health Technology.

Who are BrainSee's competitors?

Companies similar to BrainSee include Pharmbid, FINDconnect, and HealthTrunk.